Vol 26, No 5 (2019)
Editorial
Published online: 2019-09-19

open access

Page views 3219
Article views/downloads 5085
Get Citation

Connect on Social Media

Connect on Social Media

ISAR-REACT 5 — What have we learned?

Jacek Kubica1, Miłosz Jaguszewski2
Pubmed: 31536136
Cardiol J 2019;26(5):427-428.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Schüpke S, Neumann FJ, Menichelli M, et al. ISAR-REACT 5 Trial Investigators. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. N Engl J Med. 2019 [Epub ahead of print].
  2. Ibanez B, James S, Agewall S, et al. ESC Scientific Document Group . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2): 119–177.
  3. Roffi M, Patrono C, Collet JP, et al. ESC Scientific Document Group . 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016; 37(3): 267–315.
  4. Valgimigli M, Bueno H, Byrne RA, et al. ESC Scientific Document Group , ESC Committee for Practice Guidelines (CPG) , ESC National Cardiac Societies . 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018; 39(3): 213–260.
  5. Shi L, Liu J, Fonseca V, et al. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010; 8: 99.
  6. Kubica A, Kasprzak M, Obońska K, et al. Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction. Pharmacology. 2015; 95(1-2): 50–58.